Myomo, INC Form 4 insider transactions

David Henry, CFO of Myomo, Inc., sold 10,620 shares of common stock on June 10, 2024, to cover income taxes resulting from the vesting of restricted stock units.

Harry Kovelman, Chief Medical Officer of Myomo, Inc., sold 5,347 shares of common stock on June 10, 2024, to cover income taxes resulting from vesting of restricted stock units.

Micah Mitchell, Chief Commercial Officer of Myomo, Inc., sold 6,837 shares of common stock on June 10, 2024, to cover income taxes resulting from the vesting of restricted stock units.

David A. Henry, CFO of Myomo, Inc., was granted 70,000 restricted stock units (RSUs) on June 5, 2024, which vest annually over three years starting June 5, 2025.

Micah Mitchell, Chief Commercial Officer of Myomo, Inc., was granted 50,000 restricted stock units (RSUs) on June 5, 2024, which vest annually over three years starting June 5, 2025.

Harry Kovelman, Chief Medical Officer of Myomo, Inc., was granted 53,000 shares of common stock in the form of Restricted Stock Units.

Myomo CEO Paul Gudonis was granted 130,000 restricted stock units (RSUs) on June 5, 2024, which vest annually over three years starting June 5, 2025.

Director Thomas F. Kirk received a grant of 12,034 restricted stock units in Myomo, Inc.

Director Morris Milton Mayo reported acquiring 12,034 shares of Myomo, Inc. common stock through a grant of Restricted Stock Units.

Director Thomas Crowley Jr. received a grant of 12,034 restricted stock units in Myomo, Inc.

Heather C. Getz, a director at Myomo, Inc., acquired 12,034 shares of common stock on June 5, 2024, through a grant of Restricted Stock Units.

Director Amy K. Knapp reported acquiring 12,034 shares of Myomo, Inc. common stock through a grant of Restricted Stock Units.

Harry Kovelman, Chief Medical Officer of Myomo, Inc., sold 121 shares of common stock on June 3, 2024, to cover income taxes resulting from the vesting of restricted stock units.

Director Thomas F. Kirk of Myomo, Inc. recently purchased 50,000 shares of common stock at $3.50 per share, increasing his total holdings to 236,499 shares.

Harry Kovelman, Chief Medical Officer of Myomo, Inc., sold 35,426 shares of common stock at an average price of $3.6933 on May 15, 2024.

Harry Kovelman, Chief Medical Officer of Myomo, Inc., reports the sale of 146 shares of common stock to cover income taxes resulting from the vesting of restricted stock units.

Harry Kovelman, Chief Medical Officer of Myomo, Inc., reports a transaction involving the disposal of 146 shares of common stock to cover income taxes from vesting restricted stock units.

Director Thomas F. Kirk of Myomo, Inc. purchased 50,000 shares of common stock at $3.50 per share on March 14, 2024.

David A. Henry, CFO of Myomo, Inc., sold 7,774 shares of common stock on March 11, 2024, to cover income tax obligations resulting from the vesting of restricted stock units.

Harry Kovelman, Chief Medical Officer of Myomo, Inc., sold 6,590 shares of common stock on March 11, 2024, to cover income taxes resulting from the vesting of restricted stock units.

Micah Mitchell, Chief Commercial Officer of Myomo Inc., sold 5,359 shares of common stock on March 11, 2024, to cover income taxes resulting from the vesting of restricted stock units.

Harry Kovelman, Chief Medical Officer of Myomo, Inc., disposed of 147 shares of common stock on March 5, 2024, to cover income tax obligations arising from the vesting of restricted stock units.